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Purpose. To conduct a systematic review and meta-analysis to determine the current best available evidence of the efficacy and
safety of acupuncture and related therapies for acne vulgaris. Methods. Eleven English and Chinese databases were searched to
identify randomized controlled trials (RCTs) of acne vulgaris compared to pharmacotherapies, no treatment, and sham or placebo
acupuncture. Methodological quality was assessed using Cochrane Collaboration’s risk of bias tool. Meta-analysis was conducted
using RevMan software. Results. Twelve RCTs were included in the qualitative review and 10 RCTs were included in meta-analysis.
Methodological quality of trials was generally low.The chance of achieving ≥30% change in lesion count in the acupuncture group
was no different to the pharmacotherapy group (RR: 1.07 [95% CI 0.98, 1.17]; 𝐼2 = 8%) and ≥50% change in lesion count in
the acupuncture group was not statistically different to the pharmacotherapy group (RR: 1.07 [95% CI 0.98, 1.17]; 𝐼2 = 50%).
Conclusions. While caution should be exercised due to quality of the included studies, acupuncture and auricular acupressure were
not statistically different to guideline recommended treatments but were with fewer side effects and may be a treatment option.
Future trials should address the methodological weaknesses and meet standard reporting requirements stipulated in STRICTA.
1. Introduction
Acne vulgaris (acne) is a chronic and self-limiting condition
that begins in adolescence and can last over 10 years [1]. Acne
is characterized by inflamed and noninflamed comedones,
oily skin, and cysts [2]. The mechanisms for the initial
development of comedones are not fully understood [3].
Four factors have been identified which contribute to acne
lesions and are the main targets of treatment. These factors
include follicular keratinization, sebum production, Propi-
onibacterium acnes (P. acnes), and inflammatory mediator
release [4]. Acne lesions may involve cellular inflammation
causing hyperkeratinization of follicular ducts [5]. P. acnes
can induce keratinocytes to produce cytokines which rupture
ducts, causing comedones [3]. Genetics [6] and androgen
imbalances [7] can influence sebaceous gland lipid synthesis.
Exacerbation can result from single or multiple factors such
as P. acnes, menstruation, occupation, personal sweating,
diet, or stress [2, 8].
Treatment of acne includes topical benzoyl peroxide and
topical retinoids or antibiotics for mild to moderate acne
and oral antibiotics combined with either topical benzoyl
peroxide or topical or oral retinoids for severe acne [4].
Acupuncture is an umbrella term for traditional Chinese
medicine techniques that stimulate acupuncture points.
Techniques include acupuncture (insertion of fine needles
at specific loci typically for a period of 20 to 30 minutes),
auricular acupuncture (insertion of needles in specific loci
of the auricle), auricular acupressure (placement of blunt
instruments such as small metallic ball bearings at specific
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loci of the auricle), electroacupuncture (mild electric stimu-
lation of acupuncture needles) [9], andmoxibustion (burning
of Artemisia argyi Levl. et Vant or Artemisia vulgaris leaf
in a processed form) [10]. Several studies have suggested a
potential role of acupuncture techniques in acne. Auricular
acupressure and surrounding needle (where two to four
needles are inserted superficially around the acne lesion)
have been shown to reduce serum excretion rate (SER) and
testosterone [11]. When acupuncture was combined with
benzoyl peroxide, SER in women was reduced compared
to benzoyl peroxide alone [12]. In animal studies, auricular
acupuncture, auricular electroacupuncture, body acupunc-
ture, and electro-acupuncture have been shown to decrease
inflammation [13–16]. Auricular acupuncture may reduce
acne inflammation through peripheral muscarinic receptors
[13] and innate and adaptive immune responses [14, 17, 18],
thereby possibly reducing acne inflammation.
Several reviews have examined the potential benefits
of acupuncture techniques in clinical studies. A Cochrane
review on complementary therapies for acne [19] evaluated
efficacy of herbal medicine, acupuncture, cupping therapy,
dietary modifications, purified bee venom, and tea tree oil.
The review found there was a lack of evidence to support
the use of herbal medicine and acupuncture. Two system-
atic reviews of acupuncture for acne have been published,
one in English [20] and one in Chinese [21]. Cao et al.
[20] included trials which used acupuncture, cupping, and
other herbal medicines. While the number of “cured” cases
increased when acupuncture was combined with cupping,
or oral or topical herbal medicines, no benefit was found
when acupuncturewas comparedwith pharmacotherapy.The
reviewers described the methodological quality of the papers
as poor. Li et al. [21] included trials of manual acupuncture
compared to routine conventional medicine (isotretinoin
and antibiotics) or multiple Chinese medicine therapies. The
authors were unable to provide conclusions due to the poor
quality of the included trials.
These reviews included herbal medicines and techniques
not commonly used outside of China. Acupuncture is com-
monly used in clinical practice for skin conditions, yet a gap
exists in the evaluation of efficacy and safety of acupuncture
for acne vulgaris. This review will analyze acupuncture
compared to pharmacotherapies, no treatment, and sham or
placebo acupuncture to evaluate the efficacy and safety of
acupuncture and acupressure for acne vulgaris.
2. Methods
Eleven databases were searched from inception to May 2013,
with an update in May 2016. Five English (PubMed, Embase,
Allied and Complementary Medicine Database (AMED),
the Cumulative Index to Nursing and Allied Health Liter-
ature (CINAHL), and Cochrane Central Register of Con-
trolled Trials (CENTRAL)) and six Chinese databases (Chi-
nese National Knowledge Infrastructure (CNKI), Chongqing
VIP Information Company (CQVIP), Wanfang Data, Chi-
nese Biomedical Literature Database (CBM)) as well as
China’s Conference Papers Database and China Dissertation
database were searched. There were no language restrictions.
Search terms included acne vulgaris, papulo-pustular acne,
acupuncture, acupressure, moxibustion, auricular acupunc-
ture and auricular acupressure, electro-acupuncture, electro
stimulation, and variants. Moxibustion and acupressure were
included as they are commonly used techniques to directly
stimulate acupuncture points. Moxibustion in particular is
commonly combined with acupuncture, and the Chinese
term for acupuncture “zhen jiu” literally means acupuncture
and moxibustion. Search terms for study design included
randomized controlled trials, controlled clinical trials, drug
therapy, placebo, and variants.
Titles and abstracts of identified citations were scanned
to identify potentially eligible randomized controlled trials
(RCTs). Full text was retrieved when eligibility could not be
ascertained from the title and abstract. RCTs of acupuncture,
acupressure, auricular acupuncture, moxibustion, and elec-
troacupuncture compared to no treatment, sham acupunc-
ture, placebo, or conventional pharmacotherapy for acne vul-
garis were included in the review. No age, gender, ethnicity,
or language limitations were applied. Trials that included
othermodalities, as cointervention, such as pharmacotherapy
or Chinese medicine techniques other than those specified
above were excluded.
The primary outcome was the change in lesion count
measured by therapeutic effective rate (TER). Chinese
medicine guidelines recommend reporting the TER ≥50%
based on lesion count alone or a combination of lesion count
and severity [22]. Many of the studies used a TER of ≥30%
as an improvement based on Chinese medicine guidelines
from 1994 [23]. The criteria for therapeutic effective rate
from the 1994 guideline were based on a change in lesion
count and associated symptoms. For analysis, we included
data for people who achieved 30% or greater on lesion count,
irrespective of the minimum threshold used by the study for
effectiveness. Secondary outcomes included severity grading,
physician’s overall grading (physician’s assessment or self-
reporting), photographic grading, quality of life instruments,
and adverse events (AE) reports.
Data extracted included patient demographics, sample
size, dropout rate, details of the intervention and comparator,
outcome measures, results, and adverse events. Authors were
contacted if there was missing data. Verification of data was
conducted by an independent researcher (IZ).
Two researchers (KW, IZ) independently assessed
methodological quality using Cochrane Collaboration’s
risk of bias tool [24]. Trials were judged as low, unclear, or
high risk of bias for the domains of sequence generation,
allocation concealment, blinding of participants, blinding
of outcome assessors, incomplete outcome data, selective
reporting, and other forms of bias such as conflicts of
interest. For acupuncture studies, it is not feasible to blind
personnel (practitioner) [25]. Disagreements in judgments
were resolved by consulting another reviewer (TZ).
Statistical analyses were performed using Review Man-
ager 5.3.5 [26]. Dichotomous data are presented as risk ratio
(RR) and continuous data asmean difference, with 95% confi-
dence intervals (CIs). Data were analyzed for available cases.
A random effects model was used. Statistical heterogeneity
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Figure 1: Study selection flow chart.
was considered substantial when the 𝐼2 statistic was greater
than 50%. We planned to perform sensitivity analysis with
studies assessed as low risk of bias for sequence generation.
Subgroup analyses were also conducted on ≥50% and ≥30%
TER. Exploration of publication bias was planned if more
than ten studies were included in any meta-analysis. Due to
the number of included trials andmethodological quality, not
all planned analyses could be performed.
3. Results
3.1. Search Results. A total of 15,306 records with one
additional record sourced elsewhere were identified from
database searches. After removal of duplicates, screening of
titles and abstracts excluded 7,673 papers, and 2,485 full texts
were reviewed (Figure 1).
3.2. Characteristics of Studies. Twelve RCTs involving 1,026
participants met the inclusion criteria [27–38]. Ten RCTs
with 975 participants were included in the meta-analysis.
The data presented from two trials could not be reanalyzed
due to data not being available for individual groups; these
were excluded fromquantitative analysis [37, 38].The authors
were contacted for additional information; however this was
unsuccessful. All trials recruitedmale and female participants
except K. S. Kim and Y.-B. Kim [37] who recruited only male
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subjects. Participant age ranged from 13 to 37 with a median
of mean age of 23.1 years. Details of trial location, treatment
times, follow-up periods, and participant stage and duration
of condition are presented in Table 1.
The intervention most frequently used was acupuncture
(six trials) [27, 28, 31–33, 35] followed by auricular acupres-
sure (two trials) [29, 30]. One trial used electroacupuncture
[36] and one trial used acupuncture combined with moxi-
bustion [34]. The comparators are described in Table 2. K.
S. Kim and Y.-B. Kim 2012 [37] included three treatment
arms, one of acupuncture alone, one of herbal medicine
alone, and one where herbal medicine was combined with
acupuncture. These three groups were compared with a wait
list control. Only the data for the acupuncture arm was
included in this analysis. McKee et al. 2004 [38] included
two treatment arms, auricular acupuncture and auricular
electroacupuncture which were compared to placebo control
groups, sham auricular acupuncture, and sham auricular
electroacupuncture, respectively.
There was large variation in acupuncture points used
(Table 2). Three studies [27, 28, 34] used CV13 Shang-
wan, CV12 Zhongwan, CV4 Guanyuan, CV6 Qihai, ST24
Huaroumen, ST26Wailing, Shang Feng Shi Dian (an abdom-
inal point 0.5 cun lateral to ST 24 Huaroumen), and KI13
Qixue. Most of the studies used a standardized set of
acupuncture points with one study using a semistandardized
approach [30]. Four studies used Ashi points [28, 29, 33, 34]
where the location was not specified and two used needles
around acne lesions (surrounding acupuncture [29, 33]).
One trial [29] reported on therapeutic effective rate based
on lesion count and severity and also reported on serum
testosterone and recurrence rate. Four trials [27, 31, 34, 35]
reported on therapeutic effective rate according to the 2002
Chinese medicine research guidelines [22]. One trial [33]
used the Chinese medicine research guidelines from 1997
[39] and three trials [28, 32, 36] used the 1994 Chinese
medicine research guidelines [23]. One trial did not refer
to a guideline for judgment of therapeutic effective rate but
indicated an improvement of lesion of 95% was a cure and
60%was a significant improvement; these data were included
in themeta-analysis [30].The criteria for determining clinical
effect are described in Supplementary Table 1. Only one trial
reported measuring quality of life, using Skindex 29 [37].
3.3. Risk of Bias. Methodological quality of the trials was
generally low (Figure 2). Four trials [28, 29, 32, 35] were
assessed as high risk of bias in the domain of sequence
generation as they used sequence of visit for randomization.
Five trials [27, 31, 34, 36, 37] were assessed as low risk
as random number generators were used. Three trials were
assessed as unclear as there was insufficient information [30,
33, 38]. All trials were assessed as unclear risk in blinding of
participants. Two trials were assessed as low risk for blinding
of outcome assessors [37, 38] and ten were at unclear risk due
to insufficient information. One trial was assessed as unclear
risk for incomplete data [31] as they did not report dropout
data.One trial, Zhang et al. [36], reported on dropout but data
was reported only for those who completed the trial and thus
was assessed as high risk for incomplete outcome data. Ten
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Figure 2: Risk of bias summary.
trials were assessed as low risk for incomplete data. Two trials
were assessed as high risk for selective outcome reporting.
McKee et al. [38] stated they would include data on adverse
events but no data were presented. K. S. Kim and Y.-B. Kim
2011 indicated in their protocol [40] the use of VAS scale but
no data was reported. The remaining ten trials were assessed
as unclear as there were no trial protocols published or trial
registrations identified [27–36].
3.4. Primary Outcome: Therapeutic Effective Rate. Figure 3
presents the forest plot for TER ≥30% change in symptoms.
In the meta-analysis of the trials that defined the TER ≥30%
as improvement, the chance of achieving a 30% or greater
change in lesion count in the acupuncture group was not
different to the combined pharmacotherapy group (retinoids,
antibiotics, and other supplements) (four studies, RR: 1.07
[95% CI 0.98, 1.17] and 𝐼2 = 8%) [28, 32, 33, 36] with
low heterogeneity. Subgroup analysis of studies where the
comparator was antibiotics plus other supplements showed
the chance of a 30% or greater change in lesion count was not
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Study or subgroup Intervention
Events EventsTotal
Control
Total
Weight Risk ratio
M-H, random, 95% CI
Risk ratio
M-H, random, 95% CI
1.1.1 Acupuncture versus antibiotics & other supplements 
Total events 60 57
Total events 58 48
23 24 19He 2009 [28] 22 21.5% 1.11 [0.92, 1.34]
37 42 38Tang and Quan 2011 [33] 42 32.6% 0.97 [0.84, 1.13]
Subtotal (95% CI) 66 64 54.1% 1.03 [0.91, 1.16]
40 42Mo and Jin 2005 [32] 33 38 35.6% 1.10 [0.95, 1.26]
18 19Zhang et al. 2014 [36] 15 20 10.3% 1.26 [0.96, 1.66]
Subtotal (95% CI) 61 58 45.9% 1.13 [1.00, 1.28]
Total (95% CI) 127 122 100.0% 1.07 [0.98, 1.17]
Total events 118 105
0.5 0.7 1.51 2
Control Acupuncture therapy
1.1.2 Acupuncture versus retinoids
Heterogeneity: 2 = 0.00; 2 = 1.17, df = 1 (P = 0.28); I2 = 14%
Test for overall eﬀect: Z = 0.41 (P = 0.68)
Heterogeneity: 2 = 0.00; 2 = 0.86, df = 1 (P = 0.35); I2 = 0%
Test for overall eﬀect: Z = 1.90 (P = 0.06)
Heterogeneity: 2 = 0.00; 2 = 3.24, df = 3 (P = 0.36); I2 = 8%
Test for overall eﬀect: Z = 1.55 (P = 0.12)
Test for subgroup diﬀerences: 2 = 1.11, df = 1 (P = 0.29); I2 = 9.9%
Figure 3: Forest plot of TER ≥30% change in symptoms.
different between acupuncture and topical/oral antibiotics
and supplements group (two studies, RR: 1.03 [95% CI 0.91,
1.16] and 𝐼2 = 14%) [28, 33] with low heterogeneity. In a
subgroup analysis of the chance of a change of 30% or greater
in lesion count acupuncture was as effective as the retinoids
groups (viaminate and tretinoin) (two studies, RR: 1.13 [95%
CI 1.00, 1.28], 𝑃 = 0.06, and 𝐼2 = 0%) with no heterogeneity
[32, 36].
Figure 4 presents the forest plot for TER ≥50% change
in symptoms. In the meta-analysis of the data from the
trials that used ≥50% TER, the chance of a greater than
50% change in lesion count in the acupuncture group was
not statistically different to the pharmacotherapy group
(retinoids and antibiotics) (six studies, RR: 1.07 [95% CI 0.98,
1.17] and 𝐼2 = 50%) [27, 29–31, 34, 35]; however there
was moderate-to-substantial heterogeneity. In a subgroup
analysis, the chance of a 50% or greater change in lesion count
in the acupuncture group was not different to the retinoid
group (isotretinoin and topical tretinoin) in four studies
(four studies, RR: 1.05 [95% CI 0.93, 1.17] and 𝐼2 = 59%)
with moderate-to-substantial heterogeneity [27, 31, 34, 35].
Two auricular acupressure trials were not combined due to
differences in comparator types (one comparator was an oral
pharmaceutical and the other was a topical preparation).
Auricular acupressure was more effective compared to oral
tetracycline for TER ≥50% (one study, RR: 1.15 [95% CI 1.02,
1.31]) [29]; however there were four times more participants
in the intervention group compared to the comparator group
with no reasons provided. Another study of auricular acu-
pressure found no benefit compared to topical benzamycin
(one study, RR: 1.12 [95% CI 0.88, 11.43]) [30].
3.5. Secondary Outcomes. The paper by K. S. Kim and Y.-
B. Kim [37] was the only trial to report on quality of life
using Skindex 29 score. The data were not presented in a
way that permitted reanalysis, so the effects remain unclear.
The study authors concluded that the use of acupuncture
and Chinese herbal medicine Keigai-rengyo-to could be used
for inflammatory acne lesions but further research was
required.
A total of 127 adverse events were reported in three trials
[27, 33, 34]. The other nine did not mention any adverse
events. There were more adverse events in the control group
(98 in the control group and 29 in the intervention group).
Adverse events in the intervention group included painful
sensation (11 cases), ecchymosis (nine cases), flushing (five
cases), and itchy sensation after needle withdrawal (four
cases) which are common adverse events seen after needle
penetration and acupressure [41, 42]. In the control group,
adverse events that included dry mouth (75 cases), dry skin
and desquamation (17 cases), and gastrointestinal discomfort
(six cases) are also common adverse events following topical
benzoyl peroxide and retinoid treatment [4, 43]. No serious
adverse events were reported in the included trials.
4. Discussion
This systematic review showed that the chance of ≥30% and
≥50% improvement in acne symptoms with body acupunc-
ture, electroacupuncture, and auricular acupressure was not
statistically different from that of pharmaceuticals for acne
vulgaris. Interestingly, the magnitude of the treatment effect
and the 95%CIswere the same for the primarymeta-analyses,
regardless of which criteria were used to measure clinical
change.Thereweremore adverse events in the pharmacother-
apy/control group than in the acupuncture/intervention
group. Based on the included studies, acupuncture was well
tolerated by participants with acne vulgaris.
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1.2.1 Acupuncture versus retinoids
Total events 150 142
49Total events 245
Heterogeneity: not applicable 
1.2.3 Auricular acupressure versus benzamycin
30Total events 32
Heterogeneity: not applicable
Total events 427 221
Han 2010 [27] 42 46 44 47 21.5% 0.98 [0.87, 1.10]
48 50 41Liu and Shi 2015 [31] 50 18.2% 1.17 [1.02, 1.35]
32 36 33Wu 2011 [34] 35 18.2% 0.94 [0.82, 1.09]
You and Liu 2014 [35] 28 30 24 30 12.2% 1.17 [0.95, 1.43]
Subtotal (95% CI) 162 162 70.2% 1.05 [0.93, 1.17]
245 260 49Li et al. 2002 [29] 60 20.5% 1.15 [1.02, 1.31]
Subtotal (95% CI) 260 60 20.5% 1.15 [1.02, 1.31]
32 40 30Liu 2011 [30] 42 9.3% 1.12 [0.88, 1.43]
Subtotal (95% CI) 40 42 9.3% 1.12 [0.88, 1.43]
Total (95% CI) 462 264 100.0% 1.07 [0.98, 1.17]
0.5 0.7 1.51 2
Control Acupuncture therapy
Study or subgroup Intervention
Events EventsTotal
Control
Total
Weight Risk ratio
M-H, random, 95% CI
Risk ratio
M-H, random, 95% CI
1.2.2 Auricular acupressure versus tetracycline
Heterogeneity: 2 = 0.01; 2 = 7.24, df = 3 (P = 0.06); I2 = 59%
Test for overall eﬀect: Z = 0.80 (P = 0.43)
Test for overall eﬀect: Z = 2.27 (P = 0.02)
Test for overall eﬀect: Z = 0.90 (P = 0.37)
Test for overall eﬀect: Z = 1.59 (P = 0.11)
Test for subgroup diﬀerences: 2 = 1.31, df = 2 (P = 0.52); I2 = 0%
Heterogeneity: 2 = 0.01; 2 = 10.05, df = 5 (P = 0.07); I2 = 50%
Figure 4: Forest plot of TER ≥50% change in symptoms.
While not validated, TER is a common measure of effect
in Chinese medicine trials. The TER for acne vulgaris is a
subjective outcome that includes a change in lesion count
or severity. The Chinese research guidelines for acne from
2002 [22] suggest a ≥50% change in lesion count or severity
whereas the 1994 guidelines [23] suggested ≥30% change in
lesion count and symptoms. In this review, acupuncture was
as effective as antibiotics in trials that used the TER criteria of
a ≥30% improvement in symptoms. In the trials that used a
≥50% improvement in symptoms, auricular acupressure was
as effective as antibiotics and acupuncture was as effective as
topical and oral retinoids.There is currently no consensus on
outcomemeasures for acne though there are efforts underway
to standardize them [44]. There was only one trial that
reported on quality of life measure Skindex 29 even though
there ismounting evidence that sufferers of acne vulgarismay
experience considerable psychological and emotional burden
[45].
All trials in the quantitative analysis used retinoids
or antibiotics as the comparator. Retinoids and antibiotics
have demonstrated efficacy for acne [4]; however long term
antibiotic use can contribute to antibiotic resistance [46].
Retinoids have severe adverse effects such as teratogenicity
and should be used with caution in people of childbearing
age [46]. Acupuncture and auricular acupressure were shown
in this analysis not to be statistically different to guideline
recommended treatments but with fewer side effects andmay
be an option for those wanting an alternative treatment to
pharmaceuticals. Treatment times varied considerably across
the trials. Such variations of treatment times could introduce
clinical heterogeneity. The typical treatment duration for
body acupuncture is 20 to 30 minutes for each treatment
and treatment frequency may vary from one to five times
per week depending on the local clinical practice environ-
ment. Fibromyalgia and tension headache studies have found
20- to 30-minute needle retention, repeated stimulation on
acupuncture points (de-qi sensation), and daily or twice
weekly treatment to have better clinical outcomes compared
to less needle retention time and once-per-week treatment
[47, 48].
The findings of this review are similar to previous
reviews [20, 21]; however previous reviews included trials
that compared Chinese medicine interventions against each
other such as acupuncture compared to herbal medicines.
This review faced the same limitations as others in terms of
themethodological quality of included trials.Methodological
quality of included studies was low, with four of the twelve
studies assessed as high risk of bias and three unclear in the
domain of sequence generation. There was also insufficient
information on blinding of outcome assessors and partici-
pants.
Sample sizes were small, and none of the included studies
reported sample size calculations. Not all trials reported on
the severity of lesions. There were no follow-up assessments
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in the included trials. Statistical heterogeneity was also
detected in several subgroup analyses which were not able
to be explored due to small numbers of studies. Detailed
reporting of trial information was lacking; none of the trials
addressed all items fromConsolidated Standard of Reporting
Trials (CONSORT) [49] or Standards for Reporting Inter-
ventions in Clinical Trials of Acupuncture (STRICTA) [50]
standard reporting conventions.The STRICTA guidelines are
important to improve transparency of intervention reporting
in acupuncture clinical trials. For studies included in this
review, several items were reported well in all trials: the
type of acupuncture used, standard acupuncture name and/or
locations of acupuncture points, the number and duration
of treatment sessions, and the precise descriptions of the
controls or comparators (Supplementary Table 2). The trials
conducted in China did not provide information about prac-
titioners, the setting and context of treatment, instructions
to practitioners, and information and explanations to the
patients.This can pose an issue with reproducibility of studies
and may be a source of bias. Reporting of such details
would enhance accurate analysis and interpretation of data
and improve research reliability in acupuncture interventions
[51].
5. Conclusions
There was no statistical difference in the efficacy of acupunc-
ture compared to pharmacotherapies for acne vulgaris; how-
ever acupuncture interventions reported less adverse effects.
Poor methodological quality of trial design and lack of
consistent reporting of outcome measures from some trials
were found in this review; therefore results should be inter-
preted with caution. Future trials should include rigorous
methodological design and reporting should follow standard
reporting conventions such as CONSORT and STRICTA.
Quality of life measures and further understanding of the
mechanisms of acupuncture on acne should also be consid-
ered for future studies.
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